Glycyrrhizin enhances interleukin-10 production by liver dendritic cells in mice with hepatitis

Journal of Gastroenterology

Volumn 38, Issue 10, 2003, Pages 962-967

  Abe, Masanori ^a   Akbar, Fazle ^a   Hasebe, Aki ^a   Horiike, Norio ^a   Onji, Morikazu ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Glycyrrhizin; Interleukin 10; Liver dendritic cells

Indexed keywords

BUFFER; CONCANAVALIN A; CYTOKINE; GLYCYRRHIZIC ACID; INTERLEUKIN 10; PHOSPHATE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; DRUG MECHANISM; HEPATITIS; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER CELL CULTURE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; CONCANAVALIN A; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENES, MHC CLASS II; GLYCYRRHIZIC ACID; HEPATITIS; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-10; INTERLEUKIN-12; LIVER; MALE; MICE; MICE, INBRED C57BL; PHENOTYPE; SODIUM CHLORIDE; T-LYMPHOCYTES, HELPER-INDUCER; TIME FACTORS;

EID: 0344825278     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-003-1179-7     Document Type: Article

References (32)

1. Bell D, Young JW, Banchereau J. Dendritic cells. Adv Immunol 1999;72:255-324.
2. Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001;106:255-8.
3. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
4. Doherty DG, O'Farrelly C. Dendritic cells: regulators of hepatic immunity or tolerance? J Hepatol 2001;34:156-60.
5. Abe M, Akbar SMF, Horiike N, Onji M. Induction of cytokine production and proliferation of memory lymphocytes by murine liver dendritic cell progenitors: role of these progenitors as immunogenic resident antigen-presenting cells in the liver. J Hepatol 2001;34:61-7.
6. Abe M, Akbar SMF, Horrike N, Onji M. Inability of liver dendritic cells from mice with experimental hepatitis to process and present specific antigens. Hepatol Res 2003;26:61-7.
7. Abe M, Kajino K, Akbar SMF, Yamamura K-I, Onji M, Hino O. Loss of immunogenicity of liver dendritic cells in mouse with chronic hepatitis. Int J Mol Med 2002;9:71-6.
8. Suzuki H, Ohta Y, Takino T, Fujisawa K, Hirayama C. Effects of glycyrrhizin on biochemical tests in patients with chronic hepatitis. Asian Med J 1983;26:423-7.
9. Arase Y, Ikeda K, Murashima N, Chayama K, Tsubota A, Koida I, et al. The long-term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 1997;79:1494-500.
10. van Rossum TGJ, Vulto AG, Hop WC, Schalm SW. Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C. Am J Gastroenterol 2001;96:2432-7.
11. van Rossum TG, Vulto AG, de Man RA, Brouwer JT, Schalm SW Glycyrrhizin as a potential treatment for chronic hepatitis C. Aliment Pharmacol Ther 1998;12:199-205.
12. Abe N, Ebina T, Ishida N. Interferon induction by glycyrrhizin and glycyrrhetic acid in mice. Microbiol Immunol 1982;26:535-9.
13. Zhang YH, Isobe K, Nagase F, Lwin T, Kato M, Hamaguchi M, et al. Glycyrrhizin as a promoter of the late signal transduction for interleukin-2 production by splenic lymphocytes. Immunology 1993;79:528-34.
14. Dai JH, Iwatani Y, Ishida T, Teramura H, Kasai H, Iwakula Y, et al. Glycyrrhizin enhances interleukin-12 production in peritoneal macrophages. Immunology 2001;103:235-43.
15. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485-92.
16. Poynard T, Marcellin P, Lee SS, Niederauc C, Minuk GS, Ideo G, et al. Randomized trial of interferon alpha-2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha-2b for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998;352:1426-32.
17. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12:671-5.
18. Shiki Y, Shirai K, Saito Y, Yoshida S, Mori Y, Wakashin M. Effect of glycyrrhizin on lysis of hepatocyte membranes induced by anti-liver cell membrane antibody. J Gastroenterol Hepatol 19929:12-6.
19. Nose M, Ito M, Kamimura K, Shimizu M, Ogihara Y. A comparison of the antihepatotoxic activity between glycyrrhizin and glycyrrhetinic acid. Planta Med 1994;60:136-9.
20. Numazaki K, Nagata N, Sato T, Chiba S. Effect of glycyrrhizin, cyclosporin A, and tumor necrosis factor alpha on infection of U-937 and MRC-5 cells by human cytomegalovirus. J Leukoc Biol 1994;55:24-8.
21. Utsnomiya T, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. Glycyrrhizin (20 beta-carboxy-11-oxo-30-norolean-2-en-3 beta-yl-2-O-beta-D-glucopyranuronosyl-alpha-D-gluco-pyranosiduronic acid) improves the resistance of thermally injured mice to opportunistic infection of herpes simplex virus type 1. Immunol Lett 1995;44:59-66.
22. Utsunomiya T, Kobayashi M, Pollard RB, Suzuki F. Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal dose of influenza virus. Antimicrob Agents Chemother 1997;41:551-6.
23. Ito A, Hayashi N, Katayama K, Hagiwara H, Kasahara A, Kashiwagi T, et al. Effect of glycyrrhizin on viral replication and quasispecies in patients with type C chronic hepatitis. Int Hepatol Commun 1997;6:233-8.
24. Bourdi M, Masubuchi Y, Reilly TP, Amouzadeh HR, Martin JL, George JW, et al. Protection against acetaminophen-induced liver injury and lethality by interleukin-10: role of inducible nitric acid synthase. Hepatology 2002;35:289-98.
25. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
26. Louis H, Le Moine O, Peny MO, Quertinmont E, Fokan D, Goldman M, et al. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice. Hepatology 1997;25:1382-9.
27. Santucci L, Fiorucci S, Chiorean M, Brunori PM, Di Matteo FM, Sidoni A, et al. Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice. Gastroenterology 1996;111:736-44.
28. Knolle P, Schlaak J, Uhrig A, Kempf P, Meyer zum Buschenfelde KH, Gerken G. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol 1995;22:226-9.
29. Alfrey EJ, Most D, Wang X, Lee LK, Holm B, Kreiger NR, et al. Interferon-gamma and interleukin-10 messenger RNA are up-regulated after orthotopic liver transplantation in tolerant rats: evidence for cytokine-mediated immune dysregulation. Surgery 1995;118:399-405.
30. Khanna A, Morelli AE, Zhong C, Takayama T, Lu L, Thomson AW. Effect of liver-derived dendritic cell progenitors on Th1-and Th-2-like cytokine responses in vitro and in vivo. J Immunol 2000;164:1346-54.
31. Corinti S, Albanesi C, la Sala A, Pastore S, Girolomoni G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol 2001;166:4312-8.
32. Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001;2:725-31.